Literature DB >> 10998802

Surgical treatment of morbid obesity with biliopancreatic diversion and gastric banding: report on an 8-year experience involving 235 cases.

G Bajardi1, G Ricevuto, G Mastrandrea, M Branca, G Rinaudo, F Cali, S Diliberti, N Lo Biundo, V Asti.   

Abstract

STUDY AIM: Developments have recently been made in bariatric surgery outside the USA. The aim of this retrospective non-randomized study was to report on our experience regarding biliopancreatic diversion (BPD) and non-adjustable gastric banding (GB) in a population of 235 obese patients. PATIENTS AND METHODS: From March 1990 to March 1998, 235 obese patients were operated on, 142 by BDP and 93 by GB, via laparotomy after rigourous selection of the patient population.
RESULTS: The mean duration of surgery was 2 h 50 minutes for BPD and 1 h for GB. One postoperative death occurred due to massive pulmonary embolism. Early major complications were frequent in the BPD group (n = 21) but rare in the GB group (n = 1). Mean duration of hospitalization was 16 days in the BPD group versus 9 days in the GB group. Mean percentage excess weight loss was 48% for the GB group and 60% for the BPD group after two years. Late mortality was limited to the BPD group (3.5%). Late complications were evenly distributed between the two groups, with a prevalence of malnutrition in the BPD group and outlet stenosis in the GB group. A high incidence of band removal was recorded related to this complication (17.2%). Incisional hernias were present in both groups.
CONCLUSIONS: GB and BPD are techniques which can induce weight loss and bring about subsequent health benefits. Nevertheless, in a few patients further intervention or adaptation of the approach due to clinical failure or to a high complication rate is required. Additional research is needed regarding determination of the surgical treatment that is best adapted to the case in question, i.e., taking into consideration both the restrictive and malabsorbative aspects.

Entities:  

Mesh:

Year:  2000        PMID: 10998802     DOI: 10.1016/s0001-4001(00)00120-3

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  7 in total

1.  Interdisciplinary European guidelines for surgery for severe (morbid) obesity.

Authors:  Martin Fried; Vojtech Hainer; Arnaud Basdevant; Henry Buchwald; Mervyn Deitel; Nicholas Finer; Jan Willem M Greve; Fritz Horber; Elisabeth Mathus-Vliegen; Nicola Scopinaro; Rudolf Steffen; Constantine Tsigos; Rudolf Weiner; Kurt Widhalm
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

2.  Interdisciplinary European guidelines on metabolic and bariatric surgery.

Authors:  M Fried; V Yumuk; J M Oppert; N Scopinaro; A Torres; R Weiner; Y Yashkov; G Frühbeck
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

3.  Band and port-related morbidity after bariatric surgery: an underestimated problem.

Authors:  M V Launay-Savary; K Slim; C Brugère; E Buc; E Nini; D Forestier; J Chipponi
Journal:  Obes Surg       Date:  2008-04-12       Impact factor: 4.129

Review 4.  Evidence-based medicine: open and laparoscopic bariatric surgery.

Authors:  P Gentileschi; S Kini; M Catarci; M Gagner
Journal:  Surg Endosc       Date:  2002-01-04       Impact factor: 4.584

5.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

6.  Acute mesenteric venous thrombosis following laparoscopic Roux-en-Y gastric bypass.

Authors:  Daniel E Swartz; Edward L Felix
Journal:  JSLS       Date:  2004 Apr-Jun       Impact factor: 2.172

7.  Interdisciplinary European Guidelines on metabolic and bariatric surgery.

Authors:  Martin Fried; Volkan Yumuk; Jean-Michel Oppert; Nicola Scopinaro; Antonio J Torres; Rudolf Weiner; Yuri Yashkov; Gema Frühbeck
Journal:  Obes Facts       Date:  2013-10-11       Impact factor: 3.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.